Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Russell 2000 Growth Fund (NY:IWO)

318.56 -1.13 (-0.35%)
Streaming Delayed Price Updated: 2:27 PM EDT, Apr 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Russell 2000 Growth Fund

< Previous 1 2 3 4 Next >
News headline image
IWO vs. MGK: How Small-Cap Diversification Compares to Mega-Cap Growth ↗
From sector tilts to portfolio concentration, key differences between these ETFs could shape your approach to growth investing. 
Via The Motley Fool
Topics ETFs
News headline image
VOOG vs. IWO: Is S&P 500 Stability or Small-Cap Growth Potential the Better Buy Right Now? ↗
Expense ratios, sector focus, and portfolio makeup set these two growth ETFs apart. Here's what that means for your investment strategy. 
Via The Motley Fool
Topics ETFs Stocks
News headline image
CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗
The FDA has formally requested the full HOPE-3 clinical study report (CSR) and supporting data, Capricor said on Tuesday. 
Via Stocktwits
Bakkt Stock Rallies Nearly 20% - What’s Behind The Move? ↗
Via Stocktwits
Planet Labs Stock Gained 7% Today — What Is The Swedish Military Deal About? ↗
Via Stocktwits
Why Did AQST Stock Plunge 40% In Pre-Market Today? ↗
Via Stocktwits
Why Did Kratos Defense Stock Surge 17% Today? ↗
Via Stocktwits
News headline image
IWY vs. IWO: IWY Goes Heavy on Big Tech, While IWO Focuses on Small Caps. Is Either One a Must-Own ETF? ↗
Explore how each ETF’s approach to diversification and sector focus shapes the balance between risk and opportunity for growth investors. 
Via The Motley Fool
Topics ETFs
News headline image
Why Did CRMD Stock Crash 28% Today? ↗
CorMedix announced that for 2026, it expects revenue between $300 million and $320 million, compared to $310 million it reported in the full year 2025, according to preliminary data. 
Via Stocktwits
News headline image
Better Growth ETF: Vanguard's MGK vs. iShares' IWO ↗
Expense ratios, sector bets, and portfolio concentration set these two growth ETFs apart in ways that matter for different investor goals. 
Via The Motley Fool
Topics ETFs
News headline image
IWO Offers Broader Diversification but Slower Growth Than VOOG ↗
Explore how sector mix and company size shape the risk and diversification profiles of these two growth-focused ETFs. 
Via The Motley Fool
Topics ETFs
Why Is SELLAS Life Sciences Stock Falling Today? ↗
Via Stocktwits
SoundHound, Apivia Deploy Agentic AI For Insurance Contact Centers: Retail Sentiment Jumps ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Which Growth Stock ETF is Better: Vanguard's VONG or iShares' IWO? ↗
Explore how each ETF’s sector mix, risk profile, and cost structure could shape your growth investing strategy. 
Via The Motley Fool
Topics ETFs
News headline image
IWM and IWO Provide Small-Cap Diversification, But One Offers More Growth Potential for Investors ↗
Compare how sector focus, cost, and risk profiles set these two small-cap ETFs apart for different investor priorities. 
Via The Motley Fool
Topics ETFs
News headline image
VUG vs. IWO: Is Large-Cap Growth or Small-Cap Diversification a Better Choice for Investors? ↗
Two growth ETFs, two distinct strategies -- see how cost, sector mix, and risk profiles set these funds apart for investors. 
Via The Motley Fool
Topics ETFs
SoundHound Stock Surged 13% Today – And Ladenburg Thalmann Has A New Price Target ↗
Via Stocktwits
News headline image
Could Buying the iShares Russell 2000 Growth ETF (IWO) Today Set You Up for Life? ↗
It's a good option if you're looking to add small-cap stocks to your portfolio. But it's not your only good option. 
Via The Motley Fool
Topics ETFs Economy Retirement
News headline image
VONG vs. IWO: Does Large-Cap Growth or Small-Cap Diversification Pay Off More for Investors? ↗
VONG has a few clear advantages, but don't discount IWO's edge when it comes to diversification. 
Via The Motley Fool
Topics ETFs
News headline image
Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today? ↗
The company said that its investigational drug did not meet its goal in a study, and no statistically significant differences between placebo and treatment arms were observed after preliminary review... 
Via Stocktwits
News headline image
SoundHound Retail Traders Brace For More Stock Gains After Voice AI Player Reports ‘Strongest-Ever Quarter’ ↗
The company’s Q2 revenue soared 217% year-over-year to $42.68 million, sharply higher than the $32.9-million consensus estimate. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
SoundHound AI Keeps Retail Sentiment High After Vanguard Stake Build Adds Momentum To Stock Rally ↗
The Koyfin-compiled consensus analysts’ price target for SoundHound stock is $11.81, implying roughly 7% downside potential from Tuesday’s closing price. 
Via Stocktwits
Topics Artificial Intelligence Workforce
News headline image
Rocket Lab Stock Soars To Record High On First-Ever ESA Contract To Launch Low-Earth Navigation Satellites ↗
As a part of the mission, Rocket Lab has been roped in to deploy the first pair of satellites to test the ESA’s proposed future low Earth orbit positioning, navigation, and timing constellation. 
Via Stocktwits
Topics Government
News headline image
UroGen Soars On Price Target Upgrade On Heels Of FDA Approval For Cancer Medicine: Retail Sees Stock Touching $20 ↗
The new price target of $30 implies a near 171% upside to the stock’s closing price of $11.08 on Thursday. 
Via Stocktwits
News headline image
UroGen Stock Slumps After FDA Advisory Committee Flag Concerns On Its Investigational Drug: But Retail’s Unruffled ↗
The Food and Drug Administration is expected to conclude its review of UroGen’s UGN-102 application by June 13. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Gambling.com Stock Dips Despite Q1 Earnings Beat ↗
The company’s revenue jumped 39%, with marketing services and sports data services increasing 13% and 405% respectively. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Aurinia Stock Rallies On Upbeat Q1 Earnings, CEO Expects Strong Performance in 2025: Retail Sentiment Brightens ↗
The company also reiterated its full-year total revenue guidance of $250 million to $260 million and net product sales guidance of $240 million to $250 million. 
Via Stocktwits
News headline image
Trump Sued By Small Businesses Over Tariffs, Alleging Misuse Of Emergency Economic Powers ↗
According to CNBC, five small companies represented by Liberty Justice Center, a nonprofit legal aid group, filed the lawsuit in the U.S. Court of International Trade. 
Via Stocktwits
Topics Economy Government Lawsuit
News headline image
Krispy Kreme’s Brazil Expansion Offers A Sweet Spot After Brutal Q4 Print, But Retail Stays Cautious ↗
The store will open in the Avenida Juscelino Kubitschek neighborhood in São Paulo in late April. The expansion is through a minority-interest joint venture with convenience store chain AmPm. 
Via Stocktwits
News headline image
The One Group Stock Slides After-Market On Mixed Q4 Earnings: Retail Leans Optimistic ↗
Its Q4 comparable sales decreased 4.3% year-over-year, said the company. 
Via Stocktwits
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.